Chen et al. showed that in vitro treatment of CRC cells with the KDM5C inhibitor KDM5A-IN-1 increased the H3K4me3 level of the tumor suppressor methyltransferase-like 14 promoter, thereby promoting its expression [153]. This evidence concerns the gene KDM5C and colorectal carcinoma.